BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33563906)

  • 1. A clinical perspective on plasma cell leukemia; current status and future directions.
    Tuazon SA; Holmberg LA; Nadeem O; Richardson PG
    Blood Cancer J; 2021 Feb; 11(2):23. PubMed ID: 33563906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary plasma cell leukemia 2.0: advances in biology and clinical management.
    Neri A; Todoerti K; Lionetti M; Simeon V; Barbieri M; Nozza F; Vona G; Pompa A; Baldini L; Musto P
    Expert Rev Hematol; 2016 Nov; 9(11):1063-1073. PubMed ID: 27759436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
    Mina R; Joseph NS; Kaufman JL; Gupta VA; Heffner LT; Hofmeister CC; Boise LH; Dhodapkar MV; Gleason C; Nooka AK; Lonial S
    Cancer; 2019 Feb; 125(3):416-423. PubMed ID: 30332496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Plasma Cell Leukemia: Identity Card 2016.
    Musto P; Simeon V; Todoerti K; Neri A
    Curr Treat Options Oncol; 2016 Apr; 17(4):19. PubMed ID: 26995215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on biology, diagnosis and treatment of primary plasma cell leukemia.
    Musto P; Statuto T; Valvano L; Grieco V; Nozza F; Vona G; Bochicchio GB; La Rocca F; D'Auria F
    Expert Rev Hematol; 2019 Apr; 12(4):245-253. PubMed ID: 30905220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advances in the treatment of primary plasma cell leukemia: a focus on hematopoietic cell transplantation.
    Nishihori T; Abu Kar SM; Baz R; Alsina M; Harousseau JL; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1144-51. PubMed ID: 23416092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the Diagnosis and Therapy of Primary Plasma Cell Leukemia -Review].
    Wang H; Li JY; Sun C; Zhou X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1837-1841. PubMed ID: 29262927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria.
    Yan W; Fan H; Xu J; Liu J; Li L; Du C; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
    Leuk Lymphoma; 2022 Dec; 63(12):2955-2964. PubMed ID: 35819882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells.
    van de Donk NWCJ
    J Clin Oncol; 2023 Mar; 41(7):1342-1349. PubMed ID: 36450104
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
    Nandakumar B; Kumar SK; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Go RS; Jevremovic D; Kyle RA; Gertz MA; Rajkumar SV; Gonsalves WI
    Mayo Clin Proc; 2021 Mar; 96(3):677-687. PubMed ID: 33673918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary plasma cell leukaemia in a 39-year-old man.
    Kasinathan G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32709663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.
    Ganzel C; Rouvio O; Avivi I; Magen H; Jarchowsky O; Herzog K; Cohen Y; Tadmor T; Horwitz NA; Leiba M; Nagler A; Cohen Y; Bulvik S; Polliack A; Rowe JM; Gatt ME;
    Leuk Res; 2018 May; 68():9-14. PubMed ID: 29501828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.
    Gavriatopoulou M; Musto P; Caers J; Merlini G; Kastritis E; van de Donk N; Gay F; Hegenbart U; Hajek R; Zweegman S; Bruno B; Straka C; Dimopoulos MA; Einsele H; Boccadoro M; Sonneveld P; Engelhardt M; Terpos E
    Leukemia; 2018 Sep; 32(9):1883-1898. PubMed ID: 30038381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
    Li WJ; Wang FR; Wen L; Chen Y; Chen H; Huang XJ; Lu J
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):801-806. PubMed ID: 32987483
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary plasma cell leukemia in the era of new drugs: has something changed?
    Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F; Bochicchio GB; Cavo M; Boccadoro M; Palumbo A
    Crit Rev Oncol Hematol; 2012 May; 82(2):141-9. PubMed ID: 21719304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du MyĆ©lome.
    Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
    J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary plasma cell leukemia presenting as a thoracic mass.
    Igala M; Bopaka RG; Khtabi W; Benchekroun S; Quessar A
    Pan Afr Med J; 2014; 19():39. PubMed ID: 25667701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
    Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.